ByHeart infant formula (infant botulism)
An FDA investigation tied a 2025 infant botulism outbreak to ByHeart formula. Cases are now in a new federal case group, and no claims have been decided.
- Case group
- MDL 3178
- Court
- S.D. New York
- Centralized
- Apr 2, 2026
- Pending cases
- 22Oct 1, 2026
We're not accepting review requests here
MDL 3178 was created in April 2026 with 22 pending actions (JPML, Oct 1, 2026). FDA's root-cause investigation is ongoing, so we track it and provide information only.
See campaigns accepting reviewsWhere things stand
New to federal case groups? Read what an MDL is and how a mass tort claim works.
- Nov 11, 2025ByHeart recalled all of its infant formula after a recall that began Nov 8, 2025.
- Feb 26, 2026CDC declared the infant botulism outbreak over.
- Jun 3, 2026FDA completed on-site inspections of ByHeart facilities. The root cause remains under investigation.
Records that usually help
You don't need these to start. Don't upload them here. A firm will ask if it needs them.
- Can or lot-number photos or receipts
- Hospital and treatment records
- Lab confirmation of infant botulism
- Contact with the health department, if any
About filing deadlines
Deadlines to file a claim vary by state and situation, and some may already have passed. Only a licensed attorney can tell you whether a deadline applies to you. Submitting here does not stop any deadline. Read how filing deadlines work.
Related campaigns
Attorney advertising. TortMatics (FusionByte Media LLC) is not a law firm. Information on this page is general and is not medical or legal advice. Talk to a doctor before changing any medication.